Pacific Biosciences Of California, INC. (PACB) — 8-K Filings

8-K Filings (16)

• 8-K Filing — Nov 5, 2025
• PacBio Reports Director Changes and Executive Appointments — Jun 6, 2025 Risk: medium
  Pacific Biosciences of California, Inc. (PacBio) filed an 8-K on June 6, 2025, reporting on several key events that occurred on June 4, 2025. These include the
• PACB Files 8-K on Operations and Financials — May 8, 2025 Risk: low
  On May 8, 2025, Pacific Biosciences of California, Inc. (PACB) filed an 8-K report. The filing primarily concerns the company's results of operations and financ
• PacBio Files 8-K on Financials and Exit Costs — Apr 9, 2025 Risk: medium
  On April 9, 2025, Pacific Biosciences of California, Inc. (PacBio) filed an 8-K report. The filing primarily concerns the company's financial condition and resu
• PacBio CFO Departs; New Directors Appointed — Mar 27, 2025 Risk: medium
  Pacific Biosciences of California, Inc. (PacBio) announced on March 24, 2025, the departure of its Chief Financial Officer, Christian O. Knutson, effective Marc
• PacBio Enters Material Definitive Agreement — Mar 13, 2025 Risk: medium
  On March 7, 2025, Pacific Biosciences of California, Inc. (PacBio) entered into a material definitive agreement. This filing also indicates the creation of a di
• PacBio Files 8-K on Financials — Feb 13, 2025 Risk: low
  On February 13, 2025, Pacific Biosciences of California, Inc. (PACB) filed an 8-K report. The filing primarily concerns the company's financial condition and re
• PacBio Announces Director Changes and Compensatory Arrangements — Jan 30, 2025 Risk: low
  On January 24, 2025, Pacific Biosciences of California, Inc. (PacBio) filed an 8-K report detailing the departure of Director Dr. Susan J. Molineaux and the app
• PacBio Files 8-K on Operations and Financials — Jan 14, 2025 Risk: low
  On January 14, 2025, Pacific Biosciences of California, Inc. (PacBio) filed an 8-K report. The filing primarily concerns the company's results of operations and
• PacBio Appoints New Chief Medical Officer — Dec 6, 2024 Risk: low
  Pacific Biosciences of California, Inc. (PacBio) announced on December 5, 2024, the appointment of Dr. Sarah E. Michaels as Chief Medical Officer. Dr. Michaels
• PacBio Files 8-K: Material Agreements, Financial Obligations, Equity Sales — Nov 22, 2024 Risk: medium
  On November 21, 2024, Pacific Biosciences of California, Inc. (PacBio) filed an 8-K report detailing several significant events. These include entering into a m
• PacBio Enters Material Definitive Agreement, Reports Equity Sales — Nov 7, 2024 Risk: medium
  On November 7, 2024, Pacific Biosciences of California, Inc. (PacBio) entered into a material definitive agreement related to a direct financial obligation. The
• PacBio Announces Board Changes and Officer Appointments — Jun 20, 2024 Risk: medium
  On June 18, 2024, Pacific Biosciences of California, Inc. (PacBio) announced changes to its Board of Directors, including the election of new directors and the
• PacBio Files 8-K: Operations, Costs, and Financials — Apr 16, 2024 Risk: medium
  On April 16, 2024, Pacific Biosciences of California, Inc. filed an 8-K report detailing financial results and other events. The filing includes information on
• PacBio Files 8-K on Financial Results and Exhibits — Feb 15, 2024 Risk: low
  Pacific Biosciences of California, Inc. filed an 8-K on February 15, 2024, to report on its results of operations and financial condition. The filing also indic
• PACB Files 8-K on Financial Condition, NASDAQ Listing Confirmed — Jan 8, 2024
  Pacific Biosciences of California, Inc. (PACB) filed an 8-K on January 8, 2024, to report on its financial condition and other events. This filing indicates tha

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX